AI-discovered drugs will be for sale sooner than you think

AI-assisted drug discovery has led to the discovery of a new antibiotic called halicin, which has the potential to kill antibiotic-resistant bacteria, marking a significant breakthrough in addressing the public health issue of superbugs; the use of AI has expedited the drug discovery process by analyzing vast amounts of medical data and predicting the properties of molecules.

vox.com

Relevant topic timeline:

8/22/2023

Global Markets for Artificial Intelligence in Drug Discovery

The global market for artificial intelligence (AI) in drug discovery is projected to grow significantly in the coming years, with emerging companies adding value and the increasing prevalence of chronic diseases driving demand, although limitations and a shortage of AI workforce may hinder growth.

8/23/2023

A map of every possible molecule could be possible with AI

Chemists are developing a chemical map of all possible molecules to accelerate the discovery process for drugs and materials, with the help of artificial intelligence to determine the properties and viability of these molecules.

8/29/2023

The company landscape for artificial intelligence in large-molecule drug discovery

Artificial intelligence (AI) techniques, particularly machine learning, are increasingly being used in drug research and development (R&D), with applications expanding beyond small molecules to include large-molecule modalities such as antibodies, gene therapies, and RNA-based therapies. These therapies, which make up a significant portion of the biopharma industry's current and future commercial potential, are expected to represent approximately 50% of the oncology market by revenue in 2030, with the majority coming from antibodies.

9/13/2023

AI Accelerates Scientific Discovery Across Fields

AI is revolutionizing scientific research by accelerating drug discovery, predicting protein structures, improving weather forecasting, controlling nuclear fusion, automating laboratory work, and enhancing data analysis, allowing scientists to explore new frontiers and increase research productivity.

9/22/2023

AI Speeds Up Patient Recruitment and Reduces Costs of Clinical Drug Trials

Major drugmakers are using artificial intelligence (AI) to accelerate drug development by quickly finding patients for clinical trials and reducing the number of participants needed, potentially saving millions of dollars. AI is increasingly playing a substantial role in human drug trials, with companies such as Amgen, Bayer, and Novartis using AI tools to scan vast amounts of medical data and identify suitable trial patients, significantly reducing the time and cost of recruitment. The use of AI in drug development is on the rise, with the US FDA receiving over 300 applications that incorporate AI or machine learning in drug development from 2016 through 2022.